Exelgyn is a French pharmaceutical company specialized in women’s healthcare. Exelgyn was founded by the innovators in the termination of pregnancy field. The company is a pioneer in development and commercialization of the first selective progesterone receptor modulator (SPRM) in gynecology.
Exelgyn is partner in the area of women's healthcare with high quality products and services designed for healthcare professionals and their patients.
Currently, Exelgyn’s products are registered and marketed in more than 30 countries where abortion is legal and where there is a medical infrastructure.